FDA Grants 510(k) Clearance to ArtVentive’s EOS-X Endoluminal Occlusion System

The FDA has granted 510(k) clearance to ArtVentive Medical Group’s EOS-X endoluminal occlusion system for arterial and venous embolization in the peripheral vasculature.

The EOS-X system is indicated for permanent occlusion in vessels from 2- to 16-mm in diameter.

The San Marcos, Calif.-based company, which specializes in embolization technology, is developing a platform of devices for embolization, interventional oncology and structural heart disease.